Look Ahead: Generic Drug Industry

Generics Industry Faces Profitability Questions, Patent Policy Shifts

By Beth Wang / January 27, 2020 at 5:31 PM
The future direction of the generic drug market is in question as the industry experiences increased competition among multiple companies all vying for the same molecule. One expert told Inside Health Policy increased competition, while good for consumers, is making drug makers rethink their place in the generics space, and some wonder whether it will lead to consolidation or increased focus on more specialty drugs. At the same time, the generic industry faces possible changes to patent settlement litigation...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.